Trulieve posts Q4 revenue of USD 293 million (-3%)
TRULITE INC TRUL | 0.00 | 0.00% |
Trulieve reported Q4 FY2025 revenue of USD 293 million (-3.0%), with a 60% gross margin and GAAP gross profit of USD 175 million. Net loss attributable to common shareholders was USD 43 million, while adjusted EBITDA was USD 105 million (36% margin). Cash flow from operations totaled USD 59 million and free cash flow was USD 56 million in Q4. For FY2025, Trulieve posted revenue of USD 1.2 billion, with 94% of revenue from retail sales, and a 60% gross margin (GAAP gross profit of USD 711 million). Net loss attributable to common shareholders was USD 116 million; adjusted EBITDA was USD 427 million (36% margin). Cash flow from operations was USD 273 million and free cash flow was USD 229 million. Cash and cash equivalents were USD 256 million at year-end. Business updates included record 50.1 million branded product units sold in FY2025 (+5.0%), expansion of its rewards program to 915,000 members, and 233 retail locations nationwide at year-end after adding 11 dispensaries in 2025. In Q4, Trulieve launched a new Florida mobile app and opened a dispensary in Findlay, Ohio; more recently it opened a dispensary in Fort Myers, Florida and said it now operates 234 retail dispensaries and over four million square feet of cultivation and processing capacity. The company also received conditional approval for a dispensing organization license under the Texas Compassionate Use Program and reported redeeming USD 368 million of senior secured notes due 2026, repaying a USD 15.8 million mortgage, and closing a USD 140 million private placement of senior secured notes due 2030. CEO Kim Rivers cited momentum into 2026, highlighting expanded access, loyal customers, branded products and growth initiatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202602260615CANADANWCANADAPR_C8538) on February 26, 2026, and is solely responsible for the information contained therein.
